These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5004804)

  • 1. [Adrenal function test as an indicator of the sensitivity of the hematopoietic system to Thio-TEPA in the combined and complex therapy of cancer of the uterine corpus].
    Khyl'ko AS; Syrota IG
    Pediatr Akus Ginekol; 1971; 4():57-9. PubMed ID: 5004804
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of agranulocytosis following use of thio-TEPA].
    Vagina OG; Vasiliev AK
    Pediatr Akus Ginekol; 1972 Oct; 5():61-2. PubMed ID: 4633307
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the coagulating and anticoagulating systems of the blood in uterine cervix cancer patients following administration of massive doses of thio-TEPA].
    Kuliev ShB; Mamedov UA
    Vopr Onkol; 1969; 15(5):49-54. PubMed ID: 4243323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of thio-TEPA and benzo-TEPA on the glycogen forming function of the liver in rabbits].
    Zel'vin BM
    Vopr Onkol; 1967; 13(3):76-9. PubMed ID: 4972958
    [No Abstract]   [Full Text] [Related]  

  • 5. [Agranulocytic reaction associated with thio-tepa therapy].
    Kirko EI; Veshler VM; Tarasenko OP
    Klin Med (Mosk); 1971 May; 49(5):131-2. PubMed ID: 5003827
    [No Abstract]   [Full Text] [Related]  

  • 6. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N
    Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the functional state of the liver following endolymphatic administration of massive doses of thio-TEPA to patients with cancer of the uterine cervix].
    Moshkov BM; Ivanov OA
    Pediatr Akus Ginekol; 1972; 3():56-8. PubMed ID: 4633214
    [No Abstract]   [Full Text] [Related]  

  • 8. MORPHOLOGICAL CHANGES IN HUMAN TUMOURS TREATED BY THIO-TEPA.
    PRESS BO
    Acta Unio Int Contra Cancrum; 1964; 20():419-20. PubMed ID: 14151947
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse effect of thio tepa on the hemopoiesis and complications arising with it].
    Andriukin AA; Vinogradova ON; Akhtomova LV
    Sov Med; 1968 Sep; 31(9):127-9. PubMed ID: 4989665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thio-tepa in the treatment of vesical papilloma].
    Quénu L
    J Urol Nephrol (Paris); 1971; 77(7):628-9. PubMed ID: 4998059
    [No Abstract]   [Full Text] [Related]  

  • 11. [Function of the diencephalo-hypophyso-adrenal axis in patients treated with telecobaltotherapy for uterine neoplasms].
    Malato M
    Rass Int Clin Ter; 1972 Feb; 52(4):233-7. PubMed ID: 5022290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Teratogenic effect of thio-tepa despite use of safety rules].
    Krarup-Hansen A
    Ugeskr Laeger; 1988 Oct; 150(40):2416-7. PubMed ID: 3144784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endolymphatic polychemotherapy in treating cancer of the corpus uteri].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Ogorodnikova LS; Shurygina EA
    Vopr Onkol; 1980; 26(3):73-7. PubMed ID: 6768194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An autopsy case of atypical leukemia occurring during thio-Tepa administration].
    Nakanuma Y; Ohta G; Saiki S; Ohta M; Hisazumi H
    Rinsho Ketsueki; 1976 Jan; 17(1):75-81. PubMed ID: 823348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in the combined treatment of far-advanced cancer of the ovaries with thio-tepa].
    DANILOV IV
    Kazan Med Zh; 1963; 3():64-6. PubMed ID: 14024959
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECTS OF COMBINED TREATMENT WITH AN ANTI-CANCER AGENT (THIO-TEPA) AND ADRENOCORTICAL STEROIDS FOR PROSTATIC CARCINOMA].
    KURODA K; HISAZUMI H; WADA I; SHIRAI K
    Gan No Rinsho; 1964 Oct; 10():736-44. PubMed ID: 14246608
    [No Abstract]   [Full Text] [Related]  

  • 17. [The combination of thio-tepa and 5 fluorouracil as a palliative therapy for breast cancer].
    Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M
    Rev Fr Gynecol Obstet; 1973 Mar; 68(3):159-65. PubMed ID: 17472211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the hyperestrogenism of endometrial cancer of ovarian or adrenal origin?].
    Hustin J; Buret J
    Bull Soc R Belge Gynecol Obstet; 1967; 37(5):405-13. PubMed ID: 5606212
    [No Abstract]   [Full Text] [Related]  

  • 19. Inappropriate antidiuretic hormone secretion after high-dose thiotepa.
    Sica S; Cicconi S; Sorà F; Chiusolo P; Piccirillo N; Laurenti L; La Barbera EO; Giordano G; Leone G
    Bone Marrow Transplant; 1999 Sep; 24(5):571-2. PubMed ID: 10482945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Hara J; Osugi Y; Ohta H; Matsuda Y; Nakanishi K; Takai K; Fujisaki H; Tokimasa S; Fukuzawa M; Okada A; Okada S
    Bone Marrow Transplant; 1998 Jul; 22(1):7-12. PubMed ID: 9678789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.